Several steps in the clinical evolution of human neoplasia are associated with a variety of recurrent chromosomal defects that could prove essential to the understanding of cancer. We found 15 types of nonrandom chromosomal abnormalities in a study of 71 patients with follicular lymphoma; 10 of the types appeared to influence the histopathological findings, clinical course, or response to treatment. A translocation, t(14;18), observed in 85 percent of all patients appeared to be the main determinant of a follicular pattern. Ten patients with a t(14;18) as a single defect had the histologic features of follicular small cleaved-cell lymphoma. Most did not require treatment for one to four years, because their tumors had an initial indolent course. In contrast, patients with follicular small cleaved-cell lymphoma with t(14;18) and deletion 13q32 acquired the hematologic features of leukemia and had an acceleration of the disease. A deletion 6q together with a complete or partial trisomy 7 or trisomy 12 (or both) was associated with the clinically more aggressive follicular mixed small- and large-cell or large-cell histologic type, which often evolves from follicular small-cell lymphoma. A complete or partial trisomy 3, 18, or 21 correlated almost exclusively with follicular large-cell lymphoma. In all follicular stages, a trisomy 2 or duplication 2p often accompanied an accelerated clinical course and a poor response to treatment. This study suggests that several discrete genomic defects may govern the evolution of a patient's malignant disease.
This article has been cited by other articles:
Paoluzzi, L., Gonen, M., Gardner, J. R., Mastrella, J., Yang, D., Holmlund, J., Sorensen, M., Leopold, L., Manova, K., Marcucci, G., Heaney, M. L., O'Connor, O. A.
(2008). Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma. Blood
111: 5350-5358
[Abstract][Full Text]
Ross, C. W., Ouillette, P. D., Saddler, C. M., Shedden, K. A., Malek, S. N.
(2007). Comprehensive Analysis of Copy Number and Allele Status Identifies Multiple Chromosome Defects Underlying Follicular Lymphoma Pathogenesis. Clin. Cancer Res.
13: 4777-4785
[Abstract][Full Text]
Cerhan, J. R., Wang, S., Maurer, M. J., Ansell, S. M., Geyer, S. M., Cozen, W., Morton, L. M., Davis, S., Severson, R. K., Rothman, N., Lynch, C. F., Wacholder, S., Chanock, S. J., Habermann, T. M., Hartge, P.
(2007). Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood
109: 5439-5446
[Abstract][Full Text]
Radcliffe, C. M., Arnold, J. N., Suter, D. M., Wormald, M. R., Harvey, D. J., Royle, L., Mimura, Y., Kimura, Y., Sim, R. B., Inoges, S., Rodriguez-Calvillo, M., Zabalegui, N., de Cerio, A. L.-D., Potter, K. N., Mockridge, C. I., Dwek, R. A., Bendandi, M., Rudd, P. M., Stevenson, F. K.
(2007). Human Follicular Lymphoma Cells Contain Oligomannose Glycans in the Antigen-binding Site of the B-cell Receptor. J. Biol. Chem.
282: 7405-7415
[Abstract][Full Text]
Glas, A. M., Knoops, L., Delahaye, L., Kersten, M. J., Kibbelaar, R. E., Wessels, L. A., van Laar, R., van Krieken, J. H. J.M., Baars, J. W., Raemaekers, J., Kluin, P. M., van 't Veer, L. J., de Jong, D.
(2007). Gene-Expression and Immunohistochemical Study of Specific T-Cell Subsets and Accessory Cell Types in the Transformation and Prognosis of Follicular Lymphoma. JCO
25: 390-398
[Abstract][Full Text]
Gine, E, Montoto, S, Bosch, F, Arenillas, L, Mercadal, S, Villamor, N, Martinez, A, Colomo, L, Campo, E, Montserrat, E, Lopez-Guillermo, A
(2006). The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma. Ann Oncol
17: 1539-1545
[Abstract][Full Text]
de Jong, D.
(2005). Molecular Pathogenesis of Follicular Lymphoma: A Cross Talk of Genetic and Immunologic Factors. JCO
23: 6358-6363
[Abstract][Full Text]
Yeh, T.-Y., Chuang, J.-Z., Sung, C.-H.
(2005). Dynein light chain rp3 acts as a nuclear matrix-associated transcriptional modulator in a dynein-independent pathway. J. Cell Sci.
118: 3431-3443
[Abstract][Full Text]
Langenau, D. M., Feng, H., Berghmans, S., Kanki, J. P., Kutok, J. L., Look, A. T.
(2005). Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA
102: 6068-6073
[Abstract][Full Text]
Mohammad, R. M., Wang, S., Aboukameel, A., Chen, B., Wu, X., Chen, J., Al-Katib, A.
(2005). Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL [(-)-gossypol] against diffuse large cell lymphoma. Molecular Cancer Therapeutics
4: 13-21
[Abstract][Full Text]
Bowman, A., Jones, D., Medeiros, L. J., Luthra, R.
(2004). Quantitative PCR Detection of t(14;18) bcl-2/JH Fusion Sequences in Follicular Lymphoma Patients: Comparison of Peripheral Blood and Bone Marrow Aspirate Samples. J. Mol. Diagn.
6: 396-400
[Abstract][Full Text]
Katzenberger, T., Ott, G., Klein, T., Kalla, J., Muller-Hermelink, H. K., Ott, M. M.
(2004). Cytogenetic Alterations Affecting BCL6 Are Predominantly Found in Follicular Lymphomas Grade 3B with a Diffuse Large B-Cell Component. Am. J. Pathol.
165: 481-490
[Abstract][Full Text]
Akasaka, T., Lossos, I. S., Levy, R.
(2003). BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood
102: 1443-1448
[Abstract][Full Text]
Fernandez-Ruiz, E., Cabrerizo, M., Ortega, M., Blas, C., Llamas, P., Santos-Roncero, M., Nieto, S., Acevedo, A., Perez, G., Nicolas, C., Fernandez-Ranada, J. M., Arranz, R.
(2003). High Molecular Response Rate and Clinical Correlation in Patients with Follicular Lymphoma Treated with Cyclophosphamide-Vincristine-Prednisone plus Interferon {alpha} 2b. Clin. Cancer Res.
9: 2497-2503
[Abstract][Full Text]
Martinez-Climent, J. A., Alizadeh, A. A., Segraves, R., Blesa, D., Rubio-Moscardo, F., Albertson, D. G., Garcia-Conde, J., Dyer, M. J. S., Levy, R., Pinkel, D., Lossos, I. S.
(2003). Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood
101: 3109-3117
[Abstract][Full Text]
Sanchez-Beato, M., Sanchez-Aguilera, A., Piris, M. A.
(2003). Cell cycle deregulation in B-cell lymphomas. Blood
101: 1220-1235
[Abstract][Full Text]
Bosga-Bouwer, A. G., van Imhoff, G. W., Boonstra, R., van der Veen, A., Haralambieva, E., van den Berg, A., de Jong, B., Krause, V., Palmer, M. C., Coupland, R., Kluin, P. M., van den Berg, E., Poppema, S.
(2003). Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood
101: 1149-1154
[Abstract][Full Text]
Viardot, A., Moller, P., Hogel, J., Werner, K., Mechtersheimer, G., Ho, A. D., Ott, G., Barth, T. F.E., Siebert, R., Gesk, S., Schlegelberger, B., Dohner, H., Bentz, M.
(2002). Clinicopathologic Correlations of Genomic Gains and Losses in Follicular Lymphoma. JCO
20: 4523-4530
[Abstract][Full Text]
Jiang, F., Lin, F., Price, R., Gu, J., Medeiros, L. J., Zhang, H. Z., Xie, S.-S., Caraway, N. P., Katz, R. L.
(2002). Rapid Detection of IgH/BCL2 Rearrangement in Follicular Lymphoma by Interphase Fluorescence in Situ Hybridization with Bacterial Artificial Chromosome Probes. J. Mol. Diagn.
4: 144-149
[Abstract][Full Text]
Velangi, M R, Reid, M M, Bown, N, Jackson, G H, Summerfield, G P, Proctor, S J, Taylor, P R A
(2002). Acute lymphoblastic leukaemia of the L3 subtype in adults in the Northern health region of England 1983-99. J. Clin. Pathol.
55: 591-595
[Abstract][Full Text]
Lossos, I. S., Alizadeh, A. A., Diehn, M., Warnke, R., Thorstenson, Y., Oefner, P. J., Brown, P. O., Botstein, D., Levy, R.
(2002). Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc. Natl. Acad. Sci. USA
99: 8886-8891
[Abstract][Full Text]
Biagi, J. J., Seymour, J. F.
(2002). Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood
99: 4265-4275
[Abstract][Full Text]
Ott, G., Katzenberger, T., Lohr, A., Kindelberger, S., Rudiger, T., Wilhelm, M., Kalla, J., Rosenwald, A., Muller, J. G., Ott, M. M., Muller-Hermelink, H. K.
(2002). Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood
99: 3806-3812
[Abstract][Full Text]
Leroux, D., Mugneret, F., Callanan, M., Radford-Weiss, I., Dastugue, N., Feuillard, J., Le Mee, F., Plessis, G., Talmant, P., Gachard, N., Uettwiller, F., Pages, M.-P., Mozziconacci, M.-J., Eclache, V., Sibille, C., Avet-Loiseau, H., Lafage-Pochitaloff, M.
(2002). CD4+, CD56+ DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique. Blood
99: 4154-4159
[Abstract][Full Text]
Mohammad, R., Abubakr, Y., Dan, M., Aboukameel, A., Chow, C., Mohamed, A., Hamdy, N., Al-Katib, A.
(2002). Bcl-2 Antisense Oligonucleotides Are Effective against Systemic but not Central Nervous System Disease in Severe Combined Immunodeficient Mice Bearing Human t(14;18) Follicular Lymphoma. Clin. Cancer Res.
8: 1277-1283
[Abstract][Full Text]
Zhu, D., McCarthy, H., Ottensmeier, C. H., Johnson, P., Hamblin, T. J., Stevenson, F. K.
(2002). Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood
99: 2562-2568
[Abstract][Full Text]
Ness, G. O., Lybak, H., Arnes, J., Rodahl, E.
(2002). Chromosomal Imbalances in Lymphoid Tumors of the Orbit. IOVS
43: 9-14
[Abstract][Full Text]
Itoyama, T., Chaganti, R. S. K., Yamada, Y., Tsukasaki, K., Atogami, S., Nakamura, H., Tomonaga, M., Ohshima, K., Kikuchi, M., Sadamori, N.
(2001). Cytogenetic analysis and clinical significance in adult T-cell leukemia/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki. Blood
97: 3612-3620
[Abstract][Full Text]
Lossos, I. S., Levy, R.
(2000). Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the BCL-6 gene. Blood
96: 635-639
[Abstract][Full Text]
Schlegelberger, B., Zwingers, T., Harder, L., Nowotny, H., Siebert, R., Vesely, M., Bartels, H., Sonnen, R., Hopfinger, G., Nader, A., Ott, G., Muller-Hermelink, K., Feller, A., Heinz, R.
(1999). Clinicopathogenetic Significance of Chromosomal Abnormalities in Patients With Blastic Peripheral B-Cell Lymphoma. Blood
94: 3114-3120
[Abstract][Full Text]
Bea, S., Ribas, M., Hernandez, J. M., Bosch, F., Pinyol, M., Hernandez, L., Garcia, J. L., Flores, T., Gonzalez, M., Lopez-Guillermo, A., Piris, M. A., Cardesa, A., Montserrat, E., Miro, R., Campo, E.
(1999). Increased Number of Chromosomal Imbalances and High-Level DNA Amplifications in Mantle Cell Lymphoma Are Associated With Blastoid Variants. Blood
93: 4365-4374
[Abstract][Full Text]
Cuneo, A., Bigoni, R., Rigolin, G. M., Roberti, M. G., Bardi, A., Piva, N., Milani, R., Bullrich, F., Veronese, M. L., Croce, C., Birg, F., Dohner, H., Hagemeijer, A., Castoldi, G.
(1999). Cytogenetic Profile of Lymphoma of Follicle Mantle Lineage: Correlation With Clinicobiologic Features. Blood
93: 1372-1380
[Abstract][Full Text]
Mounter, P J, Lennard, A L
(1999). Classic diseases revisited: Management of non-Hodgkin's lymphomas. Postgrad. Med. J.
75: 2-6
[Abstract][Full Text]
Felgar, R. E., Steward, K. R., Cousar, J. B., Macon, W. R.
(1998). T-Cell-Rich Large-B-Cell Lymphomas Contain Non-Activated CD8+ Cytolytic T Cells, Show Increased Tumor Cell Apoptosis, and Have Lower Bcl-2 Expression Than Diffuse Large-B-Cell Lymphomas. Am. J. Pathol.
153: 1707-1715
[Abstract][Full Text]
Uckun, F. M., Herman-Hatten, K., Crotty, M.-L., Sensel, M. G., Sather, H. N., Tuel-Ahlgren, L., Sarquis, M. B., Bostrom, B., Nachman, J. B., Steinherz, P. G., Gaynon, P. S., Heerema, N.
(1998). Clinical Significance of MLL-AF4 Fusion Transcript Expression in the Absence of a Cytogenetically Detectable t(4;11)(q21;q23) Chromosomal Translocation. Blood
92: 810-821
[Abstract][Full Text]
Elenitoba-Johnson, K. S.J., Gascoyne, R. D., Lim, M. S., Chhanabai, M., Jaffe, E. S., Raffeld, M.
(1998). Homozygous Deletions at Chromosome 9p21 Involving p16 and p15 Are Associated With Histologic Progression in Follicle Center Lymphoma. Blood
91: 4677-4685
[Abstract][Full Text]
Winter, J. N., Andersen, J., Reed, J. C., Krajewski, S., Variakojis, D., Bauer, K. D., Fisher, R. I., Gordon, L. I., Oken, M. M., Jiang, S., Jeffries, D., Domer, P.
(1998). BCL-2 Expression Correlates With Lower Proliferative Activity in the Intermediate- and High-Grade Non-Hodgkin's Lymphomas: An Eastern Cooperative Oncology Group and Southwest Oncology Group Cooperative Laboratory Study. Blood
91: 1391-1398
[Abstract][Full Text]
Koduru, P. R.K., Raju, K., Vadmal, V., Menezes, G., Shah, S., Susin, M., Kolitz, J., Broome, J. D.
(1997). Correlation Between Mutation in P53, p53 Expression, Cytogenetics, Histologic Type, and Survival in Patients With B-Cell Non-Hodgkin's Lymphoma. Blood
90: 4078-4091
[Abstract][Full Text]
Previous
